Phenominer Database Results (44 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Clinical Measurement Notes Record ID Study ID
SD heart right ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77.0 days 6 0.62 mg/g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days 101103 2564
SD heart right ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189.0 days 10 0.52 mg/g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days 101105 2564
SD heart right ventricle weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189.0 days 6 0.51 mg/g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 140 days 101106 2564
SD heart left atrium weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77.0 days 6 0.07 mg/g 0.0 0.01 ex vivo method 0.0 sham lad occlusion 28 days law/bw 101112 2564
SD right atrium weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189.0 days 6 0.04 g 0.0 0.01 ex vivo method 0.0 sham lad occlusion 140 days 101118 2564
SD heart right atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77.0 days 6 0.11 mg/g 0.0 0.01 ex vivo method 0.0 lad occlusion 28 days raw/bw 101119 2564
SD heart septum weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 189.0 days 10 0.33 g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days septum 101125 2564
SD heart weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77.0 days 6 1.25 g 0.02 0.05 ex vivo method 0.0 lad occlusion 28 days 101079 2564
SD heart weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189.0 days 6 2.66 g/kg 0.04 0.1 ex vivo method 0.0 sham lad occlusion 140 days 101086 2564
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77.0 days 6 1.56 mg/g 0.03 0.07 ex vivo method 0.0 sham lad occlusion 28 days 101096 2564
SD heart left ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189.0 days 10 1.53 mg/g 0.04 0.13 ex vivo method 0.0 lad occlusion 140 days 101097 2564
SD heart left ventricle weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189.0 days 6 1.44 mg/g 0.02 0.05 ex vivo method 0.0 sham lad occlusion 140 days 101098 2564
SD heart right ventricle weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189.0 days 6 0.27 g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 140 days 101102 2564
SD right atrium weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77.0 days 6 0.04 g 0.0 0.0 ex vivo method 0.0 lad occlusion 28 days 101115 2564
SD heart septum weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 189.0 days 6 0.29 g 0.02 0.05 ex vivo method 0.0 sham lad occlusion 140 days septum 101126 2564
SD heart weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189.0 days 10 1.57 g 0.06 0.19 ex vivo method 0.0 lad occlusion 140 days 101081 2564
SD heart weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77.0 days 6 3.09 g/kg 0.03 0.07 ex vivo method 0.0 lad occlusion 28 days 101083 2564
SD heart weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77.0 days 6 2.92 g/kg 0.04 0.1 ex vivo method 0.0 sham lad occlusion 28 days 101084 2564
SD heart left ventricle weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189.0 days 10 0.87 g 0.03 0.09 ex vivo method 0.0 lad occlusion 140 days 101093 2564
SD heart right ventricle weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77.0 days 6 0.25 g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days 101099 2564
SD left atrium weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77.0 days 6 0.04 g 0.0 0.0 ex vivo method 0.0 lad occlusion 28 days 101107 2564
SD left atrium weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189.0 days 6 0.04 g 0.0 0.01 ex vivo method 0.0 sham lad occlusion 140 days 101110 2564
SD right atrium weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189.0 days 10 0.05 g 0.0 0.01 ex vivo method 0.0 lad occlusion 140 days 101117 2564
SD heart right atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189.0 days 10 0.09 mg/g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days raw/bw 101121 2564
SD heart septum weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 77.0 days 6 0.24 g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days septum 101123 2564
SD heart septum weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart septum morphology trait male 77.0 days 6 0.23 g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 28 days septum 101124 2564
SD heart left ventricle weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 189.0 days 6 0.76 g 0.03 0.07 ex vivo method 0.0 sham lad occlusion 140 days 101094 2564
SD heart right ventricle weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77.0 days 6 0.23 g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 28 days 101100 2564
SD left atrium weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77.0 days 6 0.03 g 0.0 0.0 ex vivo method 0.0 sham lad occlusion 28 days 101108 2564
SD heart right ventricle weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 77.0 days 6 0.59 mg/g 0.01 0.02 ex vivo method 0.0 sham lad occlusion 28 days 101104 2564
SD left atrium weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189.0 days 10 0.05 g 0.0 0.01 ex vivo method 0.0 lad occlusion 140 days 101109 2564
SD heart left atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 77.0 days 6 0.1 mg/g 0.0 0.01 ex vivo method 0.0 lad occlusion 28 days law/bw 101111 2564
SD heart left atrium weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189.0 days 6 0.08 mg/g 0.01 0.01 ex vivo method 0.0 sham lad occlusion 140 days law/bw 101114 2564
SD heart right atrium weight to body weight ratio sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 189.0 days 6 0.08 mg/g 0.01 0.01 ex vivo method 0.0 sham lad occlusion 140 days raw/bw 101122 2564
SD heart right atrium weight to body weight ratio sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77.0 days 6 0.1 mg/g 0.0 0.01 ex vivo method 0.0 sham lad occlusion 28 days raw/bw 101120 2564
SD heart weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 77.0 days 6 1.13 g 0.03 0.07 ex vivo method 0.0 sham lad occlusion 28 days 101080 2564
SD heart weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189.0 days 6 1.41 g 0.06 0.15 ex vivo method 0.0 sham lad occlusion 140 days 101082 2564
SD heart weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart mass male 189.0 days 10 2.78 g/kg 0.07 0.22 ex vivo method 0.0 lad occlusion 140 days 101085 2564
SD heart left ventricle weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77.0 days 6 0.67 g 0.01 0.02 ex vivo method 0.0 lad occlusion 28 days 101091 2564
SD heart left ventricle weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77.0 days 6 0.6 g 0.02 0.05 ex vivo method 0.0 sham lad occlusion 28 days 101092 2564
SD heart left ventricle weight to body weight ratio left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left ventricle mass male 77.0 days 6 1.67 mg/g 0.04 0.1 ex vivo method 0.0 lad occlusion 28 days 101095 2564
SD heart right ventricle weight left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right ventricle mass male 189.0 days 10 0.29 g 0.01 0.03 ex vivo method 0.0 lad occlusion 140 days 101101 2564
SD right atrium weight sham surgical control condition (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart right atrium mass male 77.0 days 6 0.04 g 0.0 0.0 ex vivo method 0.0 sham lad occlusion 28 days 101116 2564
SD heart left atrium weight to body weight ratio left anterior descending coronary artery occlusion (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. heart left atrium mass male 189.0 days 10 0.08 mg/g 0.01 0.02 ex vivo method 0.0 lad occlusion 140 days law/bw 101113 2564